🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the efficacy of ocular topic anti...
Status
Completed
Location
Virgilio Lima Gomez
Start Date
2008-04
Trial ID
NCT00900887
Treatments Being Tested
The objective of this study is to evaluate and compare the comfort of bromf...
Status
Completed
Location
Coburn-Kleinfeldt Eye Clinic
Start Date
2009-01
Trial ID
NCT00828477
The purpose of this study is to determine the safety of Nevanac 0.1% compar...
Status
Completed
Location
Contact Alcon for Trial Locations
Start Date
2006-02
Trial ID
NCT00332774
The purpose of this study was to assess the safety and efficacy of an inves...
Status
Completed
Location
Contact Alcon Call Center For Trial Locations
Start Date
2010-06
Trial ID
NCT01109173
The purpose of this study is to determine whether nepafenac is safe and eff...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00782717
The purpose of this study is to evaluate the efficacy and need for prescrib...
Status
Unknown
Location
Sheba Medical Center
Start Date
2016-11-01
Trial ID
NCT02955641
Treatments Being Tested
This study will compare the effect of two topical non-steroidal antiinflamm...
Status
Completed
Location
Virdi Eye Clinic and Laser Vision Center
Start Date
2011-05
Trial ID
NCT01475877
Treatments Being Tested
A prospective randomized trial, to evaluate post-injection comfort measures...
Status
Unknown
Location
New York Eye and Ear Infirmary
Start Date
2018-12-03
Trial ID
NCT03918590
The purpose of this study is to compare the effectiveness of Nepafenac Opht...
Status
Completed
Location
Lehmann Eye Center
Start Date
2005-09
Trial ID
NCT00333255
Treatments Being Tested
Approximately 126 subjects scheduled to undergo cataract surgery by phacoem...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT01021761
Treatments Being Tested